Skip to content

Antibiotic prescribing habits in children with infections in primary care in Latvia and the effect of a multifactorial intervention (family physician education and C reactive protein point-of-care testing) on a change of habits

Effect of combination of point-of-care C-reactive protein testing and family physician education on reducing antibiotic prescribing for children presenting with acute infections in primary care in Latvia: a randomised controlled intervention study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN34931655
Enrollment
2284
Registered
2024-07-15
Start date
2019-11-15
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reducing antibiotic prescribing for children with acute infections Infections and Infestations

Interventions

This was a randomized controlled intervention study, with randomization at the family physician (FP) practice level. The FPs were stratified according to practice location, and each stratum was divide

Sponsors

Riga Stradinš University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Current clinical signs of acute infection for less than 5 days 2. Aged 1 month up to 17 years old

Exclusion criteria

Exclusion criteria: 1. Age under 1 month 2. Re-convalescent stage of infectious disease 3. Use of antimicrobial therapy before the time of the visit

Design outcomes

Primary

MeasureTime frame
Antibiotic prescribing at the index consultation for patients with acute illnesses with symptoms less than 5 days visiting FP in face-to-face consultations, measured using dichotomous variables - prescribed, not prescribed

Secondary

MeasureTime frame
CRP testing frequency measured using continuous variable - number of tests performed and CRP level measured with Orion Diagnostica QuikRead go CRP POCT system during index consultation using four categories (100 mg/L)

Countries

Latvia

Contacts

Public ContactZane Likopa
zane.likopa@bkus.lv+371 (0)29482308

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026